| Contacts with the National Agency for Medication for inclusion of novel treatment drugs in the Oncological program. | Kræft
> Kræft: blod | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 1.000 | National | Sometimes | 119014463919 |
| Tebentafusp [a targeted immunotherapy used to treat unresectable or metastatic uveal melanoma (a rare eye cancer)] recently, checkpoint inhibitors and Brafi [B-Raf proto-oncogene, serine/threonine kinase inhibitor - targeted cancer therapy]/Meki [Mitogen-Activated Protein Kinase Kinase 1/2 inhibitor - targeted cancer therapy] therapies in the past. | Kræft
> Kræft: hud | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 5.000 | National | Regularly | 119074557103 |
| To Ministry of Health, National Health insurance [Romania]. | Neurologisk
> Multipel sklerose | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | 5.000 | National | Sometimes | 119035936899 |
| Contacts with the National Agency for Medication for inclusion of novel treatment drugs in the Oncological program. | Kræft
> Kræft: blod | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 1.000 | National | Sometimes | 119014463919 |
| The federation is the watchdog for cancer patients' access to treatment. | Kræft
> Kræft: de fleste typer | Forbedring af adgangsveje
> Fremme retfærdig adgang til medicin/sundhedspleje | Over 100,000 | National | Regularly | 119065383407 |
| The federation [Romania] is the watchdog for cancer patients' access to treatment. | Kræft
> Kræft: de fleste typer | Forbedring af adgangsveje
> Fremme retfærdig adgang til medicin/sundhedspleje | Over 100,000 | National | Regularly | 119065383407 |
| Tebentafusp [a targeted immunotherapy used to treat unresectable or metastatic uveal melanoma (a rare eye cancer)] recently, checkpoint inhibitors and Brafi [B-Raf proto-oncogene, serine/threonine kinase inhibitor - targeted cancer therapy]/Meki [Mitogen-Activated Protein Kinase Kinase 1/2 inhibitor - targeted cancer therapy] therapies in the past. | Kræft
> Kræft: hud | Forbedring af adgangsveje
> Forbedring af adgangen til sjældne/ultrasjældne behandlinger | 5.000 | National | Regularly | 119074557103 |
| Discuss with the government about the newborn screening. | Neuromuskulær
> Spinal muskelatrofi (SMA) | Diagnose og medicinlevering
> Støtte til screening og tidlig opdagelse | 100 | National | Sometimes | 119012941830 |